N@N

Market Maker Surveillance Report. BSX, CSCO, PPDI, SPF, F, HGSI, Bullishly Biased Price Friction For Monday, December 5th 2011

^{Published on 2011-12-05 18:00:33 - WOPRAI}
 

December 5, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4007 companies with "abnormal" market making, 3776 companies with positive Friction Factors and 2257 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. BOSTON SCIENTIFIC CORP (NYSE:BSX), CISCO SYSTEMS INCORPORATED (NASDAQ:CSCO), PHARMACEUTICAL PRODUCT DEVEL (NASDAQ:PPDI), STANDARD PACIFIC CORP (NYSE:SPF), FORD MOTOR COMPANY (NYSE:F), HUMAN GENOME SCIENCES INC (NASDAQ:HGSI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     BSX        $0.120       2.18%        7,217,986       28.39%       10,128,414      39.84%       -2,910,428      Abnormal
     CSCO       $0.270       1.46%        18,519,580      41.89%       25,222,871      57.05%       -6,703,291      Abnormal
     PPDI       $0.050       0.15%        540,854         15.93%       2,853,715       84.07%       -2,312,861      Abnormal
     SPF        $0.170       5.38%        1,288,330       23.48%       3,292,708       60.00%       -2,004,378      Abnormal
     F          $0.240       2.20%        22,035,690      33.60%       24,240,450      36.96%       -2,204,760      Abnormal
     HGSI       $0.100       1.32%        2,111,797       29.89%       4,896,989       69.31%       -2,785,192      Abnormal

For example, the chart above shows BSX with 2,910,428 greater shares of selling than buying (NetVol) and the stock price was up $0.12000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.

BOSTON SCIENTIFIC CORP (NYSE:BSX) - Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. It offers cardiac rhythm management products, which monitor the heart and deliver electricity to treat cardiac abnormalities; and RF generators, intracardiac ultrasound and steerable ablation catheters, and diagnostic catheters for the diagnosis and treatment of cardiac arrhythmias. The company also provides interventional cardiology products, such as coronary stent systems, coronary revascularization products to treat patients with atherosclerosis and intraluminal catheter-directed ultrasound imaging catheters and systems; vascular access products, balloon catheters, stents and peripheral vascular catheters, wires, and accessories, as well as products for peripheral embolization procedures; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease various forms of benign and malignant tumors. In addition, it offers coated and uncoated detachable coils, micro-delivery stents, micro-guidewires, micro-catheters, guiding catheters, and embolics to neuro-interventional radiologists and neurosurgeons to treat diseases of the neurovascular system; and endoscopy and interventional bronchoscopy products to diagnose and treat various digestive diseases, as well as pulmonary disease systems within the airway and lungs. Further, the company provides urology/womens health products to treat patients with urinary stone disease, benign prostatic hyperplasia, stress urinary incontinence, pelvic organ prolapse, and excessive uterine bleeding; and spinal cord stimulation system for the management of chronic intractable pain of the trunk and/or limbs. Boston Scientific Corporation markets its products through direct sales force, and a network of distributors and dealers. The company was founded in 1979 and is headquartered in Natick, Massachusetts with additional offices in Tokyo, Japan and Paris, France.

CISCO SYSTEMS INCORPORATED (NASDAQ:CSCO) - Cisco Systems, Inc. designs, manufactures, and sells Internet protocol (IP)-based networking and other products related to the communications and information technology industry worldwide. It offers routers that interconnect public and private IP networks for mobile, data, voice, and video applications; switching products, which offer connectivity to end users, workstations, IP phones, access points, and servers; application networking services; and home networking products, such as adapters, gateways, modems, and home network management software products. The company also provides security products comprising span firewall, intrusion prevention, remote access, virtual private network, unified client, Web, and email security products; storage area networking products that deliver connectivity between servers and storage systems; unified communication products to integrate voice, video, data, and mobile applications on fixed and mobile networks; video systems, including digital set-top boxes and digital media products; and wireless systems. In addition, it offers optical networking products, cable access and flip video products, service provider VoIP services, Cisco TelePresence systems, Cisco Unified Computing Systems, physical security and video surveillances, digital media systems, and building systems. Further, the company provides technical support services; and responsive, preventive, and consultative support services for its technologies. Cisco Systems, Inc. has strategic alliances with Accenture Ltd; AT&T Inc.; Cap Gemini S.A.; EMC Corporation; Fujitsu Limited; Intel Corporation; International Business Machines Corporation; Italtel SpA; Johnson Controls Inc.; Microsoft Corporation; Nokia Corporation; Nokia Siemens Networks; Oracle Corporation; SAP AG; Sprint Nextel Corporation; Tata Consultancy Services Ltd.; VMware, Inc.; BMC Software Inc.; and Wipro Limited. The company was founded in 1984 and is headquartered in San Jose, California.

PHARMACEUTICAL PRODUCT DEVEL (NASDAQ:PPDI) - Pharmaceutical Product Development Inc., a contract research organization, provides drug discovery and development services, post-approval expertise, and compound partnering programs. Its Discovery Sciences segment offers preclinical program design, toxicology consulting, lab services, and technical writing and regulatory submissions, as well as compound collaboration programs. The Development segment provides Phase 1 clinical testing, lab services, and Phases 2 through 4 clinical trial management services (such as study design, investigator recruitment, clinical data management and bio-statistical analysis). The company also offers product launch services and patient and disease registry programs, and has operations worldwide. Pharmaceutical Product Development, founded in 1985, is headquartered in Wilmington, N.C.

STANDARD PACIFIC CORP (NYSE:SPF) - Standard Pacific Corp. operates as a diversified builder of single-family attached and detached homes in the United States. It constructs homes within various price and size ranges targeting diversified homebuyers with operations in major metropolitan markets in California, Florida, Arizona, Texas, the Carolinas, Colorado, and Nevada. The company, through its mortgage banking subsidiary, originates loans for its homebuyers, which are generally sold in the secondary mortgage market. In addition, Standard Pacific, through its title services subsidiary, acts as a title insurance agent performing title examination services for its Texas homebuyers. As of December 31, 2009, the company had 198 projects. Standard Pacific was founded in 1986 and is headquartered in Irvine, California.

FORD MOTOR COMPANY (NYSE:F) - Ford Motor Company primarily develops, manufactures, distributes, and services vehicles and parts worldwide. It operates in two sectors, Automotive and Financial Services. The Automotive sector offers vehicles primarily under the Ford and Lincoln brand names. This sector markets cars, trucks, and parts through retail dealers in North America, and through distributors and dealers outside of North America. It also sells cars and trucks to dealers for sale to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. In addition, this sector provides retail customers with a range of after-sale vehicle services and products in the areas, such as maintenance and light repair, heavy repair, collision repair, vehicle accessories, and extended service contracts under the Ford Service, Lincoln Service, Ford Custom Accessories, Ford Extended Service Plan, and Motorcraft brand names. The Financial Services sector offers various automotive financing products to and through automotive dealers. It offers retail financing, which includes retail installment contracts for new and used vehicles; direct financing leases; wholesale financing products that comprise loans to dealers to finance the purchase of vehicle inventory; loans to dealers to finance working capital, purchase real estate dealership, and/or make improvements to dealership facilities; and other financing products, as well as provides insurance services. Ford Motor Company was founded in 1903 and is based in Dearborn, Michigan.

HUMAN GENOME SCIENCES INC (NASDAQ:HGSI) - Human Genome Sciences, Inc. operates as a biopharmaceutical company. Its principal products in development include BENLYSTA for systemic lupus erythematosus; and raxibacumab for inhalation anthrax. The companys mid- and early-stage pipeline products comprise Mapatumumab for the treatment of non-small cell lung cancer, multiple myeloma, and hepatocellular cancer; IAP Inhibitors that are compounds, which block the activity of IAP (inhibitor of apoptosis) proteins, allowing apoptosis to proceed and causing the cancer cells to die; and CCR5 mAb, a human monoclonal antibody to the CCR5 receptor for the treatment of ulcerative colitis. Human Genome Sciences, Inc. also holds financial rights to certain products in the GlaxoSmithKline clinical development pipeline, including darapladib, a Phase III clinical trial product for the treatment of coronary heart disease and ischemic stroke; and Albiglutide for the treatment for type 2 diabetes, which is in Phase III clinical trial stage. The company has a license agreement with GlaxoSmithKline for the co-development and commercialization of BENLYSTA; and a collaboration and license agreement with Aegera Therapeutics, Inc. to develop and commercialize certain oncology molecules and related backup compounds. Human Genome Sciences, Inc. was founded in 1992 and is headquartered in Rockville, Maryland.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net